首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs
【24h】

The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs

机译:V莱顿因子和G20210A凝血酶原突变对特发性下肢深静脉血栓形成后残余静脉阻塞的影响

获取原文
获取原文并翻译 | 示例
           

摘要

It was our aim to assess whether factor V Leiden (FVL) and G20210A prothrombin (FII) mutation are associated with the presence of residual vein obstruction (RVO) after a standard course of anticoagulation for a first episode of idiopathic proximal deep-vein thrombosis (DVT) of the lower limbs, with or without symptomatic pulmonary embolism (PE). Patients were enrolled in two prospective multicentre studies: PROLONG and PROLONG II. RVO was detected by compression ultrasonography according to the method of Prandoni on the day of anticoagulation withdrawal. Patients were also screened for FVL and FII mutation. The presence of FVL and/or FII mutation was determined in 872/963 (90.5%) patients, in 753 of whom RVO was assessed. FVL was significantly less frequent among subjects with isolated PE (7/176:4%) than among patients with either DVT and PE (15/133:11.3%; p=0.0018) or isolated DVT (89/563:15.8%; p<0.0001), confirming the FVL paradox. The rate of FII mutation was similar among patients with isolated PE (11/176:6.2%) and patients with either DVT and PE (12/133:9%) or isolated DVT (52/563:9.2%). FVL and FII mutation were not significantly associated with RVO at the multivariate analysis in all patients, although data suggest that FVL and FII mutation may have a differential effect on RVO in the subgroups of patients with DVT and DVT plus PE patients. Male sex and isolated DVT were significantly associated with RVO in all patients. In conclusion, male sex and isolated DVT are associated with RVO, while FVL and FII mutations are not significantly associated with RVO in this study. ? Schattauer 2013.
机译:我们的目的是评估在特发性近端深静脉血栓形成的首发抗凝标准疗程后,因子V莱顿(FVL)和G20210A凝血酶原(FII)突变是否与残余静脉阻塞(RVO)的存在相关( DVT)的下肢,有无症状性肺栓塞(PE)。患者参加了两项前瞻性多中心研究:PROLONG和PROLONG II。抗凝停药当天,根据Prandoni的方法,通过压缩超声检查来检测RVO。还对患者的FVL和FII突变进行了筛查。在872/963(90.5%)患者中确定了FVL和/或FII突变的存在,其中753名患者接受了RVO评估。与孤立的DVT和PE的患者(15/133:11.3%; p = 0.0018)或孤立的DVT的患者(89/563:15.8%; p)相比,孤立的PE患者(7/176:4%)的FVL发生率显着降低<0.0001),确认FVL悖论。分离型PE患者(11/176:6.2%)和DVT和PE(12/133:9%)或分离型DVT患者(52/563:9.2%)的FII突变率相似。尽管所有数据表明FVL和FII突变可能对DVT和DVT加PE患者亚组的RVO产生不同的影响,但在所有患者中FVL和FII突变与RVO均无显着相关性。在所有患者中,男性和孤立的DVT与RVO显着相关。总之,在这项研究中,男性和孤立的DVT与RVO相关,而FVL和FII突变与RVO没有显着相关。 ?沙塔尔2013年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号